Shook David
Lyell Immunopharma, Inc. · Chief Medical Officer
Shook David is listed in filings as Chief Medical Officer at Lyell Immunopharma, Inc.. This profile follows SEC Form 4 activity through Feb 11, 2026, including sale activity. Recent filings connect the profile to Lyell Immunopharma, Inc. (LYEL) and Nkarta, Inc. (NKTX). The current snapshot covers public activity from Jun 20, 2024 to Feb 11, 2026. Reported amounts are shown as $1.2M to $19.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2.6k456 shares | SellJun 18, 2024 | $5.60 | $3.19 |